Creepy Jar SA (CRJ)
Warsaw Stock Exchange · Poland · prices in PLN · close of 23 Oct 2026
Key indicators
| Last close | PLN 366.00 |
|---|---|
| 52-week range | 350.00 – 840.00 |
| Return, 1 month / 3 months | −20.8% / −18.5% |
| Return, 1 year / 3 years | −9.6% / −31.1% |
| Trend | Below its 200-day average |
| RSI (14) | 20 |
| Volatility (1 year) | 49.3% |
| Worst drawdown (1 year) | -46.2% |
| Average daily value traded | 1.10M PLN |
| Dividend yield | 11.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Creepy Jar is a Polish video game developer based in Warsaw. The studio creates and self-publishes computer games, and it is known for the survival title Green Hell, which places players in a hostile jungle setting. Its games are made for personal computer platforms and are offered to players around the world through digital storefronts. The company focuses on developing its own game projects rather than on contract work for other publishers.
On this site Creepy Jar SA appears as a stock on the Warsaw Stock Exchange (Poland), code CRJ, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Creepy Jar SA (CRJ) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 366.00 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 392 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.6% and over the last three months it fell 18.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.1% | ||
| From 52-week high | -50.4% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.5% | ||
| 6-month return | -34.3% | ||
| 12-month return, skipping the last month | 14.1% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.2% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 1.10M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 80 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 11.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −8.7% |
|---|---|
| 1 month | −20.8% |
| 3 months | −18.5% |
| 6 months | −34.3% |
| 1 year | −9.6% |
| 3 years | −31.1% |
| 5 years | −37.2% |
Signals
| 50-day / 200-day average | 455.65 / 508.73 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Sep 2026 | PLN 41.7700 |
| 20 Jun 2025 | PLN 11.3700 |
| 21 Jun 2024 | PLN 13.1100 |
| 28 Aug 2023 | PLN 40.0000 |
| 20 Jun 2022 | PLN 21.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.